Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation

被引:32
|
作者
Broglie, Martina A. [1 ]
Soltermann, Alex [2 ]
Rohrbach, David [2 ]
Haile, Sarah R. [3 ]
Pawlita, Michael [4 ]
Studer, Gabriela [5 ]
Huber, Gerard F. [6 ]
Moch, Holger [2 ]
Stoeckli, Sandro J. [1 ]
机构
[1] Kantonsspital St Gallen, Dept Otorhinolaryngol Head & Neck Surg, CH-9007 St Gallen, Switzerland
[2] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland
[3] Kantonsspital St Gallen, Clin Trials Unit, CH-9007 St Gallen, Switzerland
[4] German Canc Res Ctr, Res Program Infect & Canc, Dept Genome Modificat & Carcinogenesis, Heidelberg, Germany
[5] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[6] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, Zurich, Switzerland
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2013年 / 35卷 / 12期
关键词
oropharyngeal squamous cell carcinoma; outcome; survival; HPV; p16; smoking; alcohol; p53; intensity modulated radiotherapy; risk stratification; GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; TONSILLAR CARCINOMAS; HEAD; RADIOTHERAPY; EXPRESSION; PROGNOSIS; RISK;
D O I
10.1002/hed.23231
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundAnalysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity-modulated radiotherapy (IMRT). MethodsOne hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%). ResultsSurvival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high-risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16-positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups. ConclusionsA risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. (c) 2013 Wiley Periodicals, Inc. Head Neck 35: 1698-1706, 2013
引用
收藏
页码:1698 / 1706
页数:9
相关论文
共 50 条
  • [21] Squamous Cell Carcinoma of the Vulva A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR)
    Dong, Fei
    Kojiro, Sakiko
    Borger, Darrell R.
    Growdon, Whitfield B.
    Oliva, Esther
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) : 1045 - 1053
  • [22] p16 and p53 can Serve as Prognostic Markers for Head and Neck Cell Carcinoma
    Wang, Yue
    Wang, Fang
    Wang, Shuhan
    Zhang, Lingnan
    Fu, Honghai
    Sun, Legang
    Wang, Wenlong
    Liu, Chunxia
    Ren, Wenhao
    Gao, Ling
    Xing, Guoyi
    Ma, Xiangrui
    INTERNATIONAL DENTAL JOURNAL, 2024, 74 (03) : 543 - 552
  • [23] Prevalence of p16 expression in oropharyngeal squamous cell carcinoma in southern Brazil
    Girardi, Fabio Muradas
    Wagner, Vivian P.
    Martins, Manoela Domingues
    Abentroth, Aliende Lengler
    Hauth, Luiz Alberto
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2020, 130 (06): : 681 - 691
  • [24] Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma
    Weiss, Bernhard G.
    Anczykowski, Mahalia Zoe
    Kueffer, Stefan
    Spiegel, Jennifer L.
    Bertlich, Mattis
    Canis, Martin
    Ihler, Friedrich
    Kitz, Julia
    Jakob, Mark
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (06) : 1983 - 2000
  • [25] Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma
    Pouwer, A. W.
    te Grootenhuis, N. C.
    Hinten, F.
    de Bock, G. H.
    van der Zee, A. G. J.
    Melchers, W. J. G.
    Oonk, M. H. M.
    de Hullu, J. A.
    Hollema, H.
    Bulten, J.
    VIRCHOWS ARCHIV, 2024, 484 (06) : 985 - 994
  • [26] Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation
    Gupta, Seema
    Khan, Huma
    Kushwaha, Vandana Singh
    Husain, Nuzhat
    Negi, M. P. S.
    Ghatak, Ashim
    Bhatt, M. L. B.
    CANCER BIOLOGY & THERAPY, 2015, 16 (09) : 1269 - 1280
  • [27] Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
    Cohen, Erin R.
    Reis, Isildinha M.
    Gomez, Carmen
    Pereira, Lutecia
    Freiser, Monika E.
    Hoosien, Gia
    Franzmann, Elizabeth J.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 157 (02) : 239 - 251
  • [28] p16 Positive Oropharyngeal Squamous Cell Carcinoma: An Entity With a Favorable Prognosis Regardless of Tumor HPV Status
    Lewis, James S., Jr.
    Thorstad, Wade L.
    Chernock, Rebecca D.
    Haughey, Bruce H.
    Yip, James H.
    Zhang, Qin
    El-Mofty, Samir K.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (08) : 1088 - 1096
  • [29] Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
    Schulte, Jefree J.
    Steinmetz, Jamie
    Furtado, Larissa, V
    Husain, Aliya N.
    Lingen, Mark W.
    Cipriani, Nicole A.
    HEAD & NECK PATHOLOGY, 2020, 14 (04) : 966 - 973
  • [30] p16 Influence on Laryngeal Squamous Cell Carcinoma Relapse and Survival
    Sanchez Barrueco, Alvaro
    Gonzalez Galan, Fernando
    Villacampa Auba, Jose Miguel
    Diaz Tapia, Gonzalo
    Hernandez, Sofia Fernandez
    Martin-Arriscado Arroba, Cristina
    Cenjor Espanol, Carlos
    Almodovar Alvarez, Carlos
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (06) : 1042 - 1047